scholarly article | Q13442814 |
P433 | issue | 5 | |
P921 | main subject | position paper | Q7233193 |
P304 | page(s) | 473-478 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Obesity | Q15763232 |
P1476 | title | Guidelines for the approval and use of drugs to treat obesity. A position paper of The North American Association for the Study of Obesity | |
P478 | volume | 3 |
Q35570030 | A benefit-risk assessment of sibutramine in the management of obesity |
Q33542534 | A risk-benefit assessment of anti-obesity drugs |
Q41445495 | Dexfenfluramine. An updated review of its therapeutic use in the management of obesity |
Q35037275 | New pharmacological tools for obesity |
Q77120988 | Orlistat |
Q28375925 | Orlistat: a review of its use in the management of obesity |
Q51565817 | Sibutramine. A review of its contribution to the management of obesity. |
Search more.